Compare ARDX & AAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARDX | AAT |
|---|---|---|
| Founded | 2007 | 1967 |
| Country | United States | United States |
| Employees | N/A | 208 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2014 | 2010 |
| Metric | ARDX | AAT |
|---|---|---|
| Price | $6.22 | $24.35 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 7 | 2 |
| Target Price | $15.14 | ★ $19.50 |
| AVG Volume (30 Days) | ★ 3.3M | 458.4K |
| Earning Date | 04-30-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 6.65% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.08 |
| Revenue | $2,607,000.00 | ★ $436,204,000.00 |
| Revenue This Year | $37.75 | $4.33 |
| Revenue Next Year | $34.24 | $0.22 |
| P/E Ratio | ★ N/A | $303.00 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.74 | $17.72 |
| 52 Week High | $8.40 | $24.85 |
| Indicator | ARDX | AAT |
|---|---|---|
| Relative Strength Index (RSI) | 57.43 | 68.34 |
| Support Level | $5.46 | $18.60 |
| Resistance Level | $6.23 | $24.85 |
| Average True Range (ATR) | 0.27 | 0.47 |
| MACD | 0.09 | -0.08 |
| Stochastic Oscillator | 78.88 | 73.49 |
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
American Assets Trust Inc is a self-administered real estate investment trust based in the United States. The company invests in, operates, and develops retail, office, residential, and mixed-use properties. Properties are predominantly located in South California, Northern California, Oregon, Washington, and Hawaii. American Assets operates through four segments based on property type: retail; office; mixed-use, which consists of retail and hotel components; and multifamily, which includes the company's apartment properties. The retail and office segments collectively contribute the majority of the total revenue.